Edition:
India

Alnylam Pharmaceuticals Announces Transition Of CFO


Thursday, 11 Jul 2019 

July 11 (Reuters) - Alnylam Pharmaceuticals Inc ::ALNYLAM PHARMACEUTICALS ANNOUNCES TRANSITION OF CHIEF FINANCIAL OFFICER.ALNYLAM PHARMACEUTICALS INC - ANNOUNCES PLANNED APPOINTMENT OF JEFF POULTON -.ALNYLAM PHARMACEUTICALS INC - MANMEET S. SONI TO RESIGN AFTER A TRANSITION PERIOD.ALNYLAM PHARMACEUTICALS INC - JEFF POULTON BEEN APPOINTED EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER (CFO), EFFECTIVE AUGUST 13, 2019.